Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China. [PDF]
Wu CQ +21 more
europepmc +1 more source
Helicobacter Pylori Eradication: Survey conducted by the Colombian Association of Gastroenterology
Martín Alonso Gómez Zuleta +4 more
openalex +1 more source
Total Neoadjuvant Therapy for Rectal Cancer: Why Japan Says “Not Yet”
ABSTRACT Total neoadjuvant therapy (TNT) has rapidly gained global acceptance as a standard treatment for locally advanced rectal cancer (LARC). Supported by multiple phase III trials, TNT improves pathological complete response (pCR) rates, enhances systemic control, and expands opportunities for non‐operative management (NOM).
Kay Uehara +4 more
wiley +1 more source
<i>Helicobacter pylori</i> persists in pancreatic ductal adenocarcinoma despite eradication therapy. [PDF]
Mehmood MS, Danaf N.
europepmc +1 more source
Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. [PDF]
Dertli R +6 more
europepmc +1 more source
Neglected tropical diseases: the need for an integrated approach to achieve the 2030 roadmap. [PDF]
europepmc +1 more source
Resistance reversal: Taiwan's <i>Helicobacter pylori</i> trends defy global norms. [PDF]
Issa T, Zalloua P, Issa IA.
europepmc +1 more source
Antimicrobial Resistance Patterns and Determinants of <i>Helicobacter pylori</i> Culture Success: A Prospective Study. [PDF]
Sohn JY +4 more
europepmc +1 more source
Is a Functional Cure Possible in Autoimmune Diseases? Evidence from Trigger Eradication, Transplantation, and Cellular Therapies. [PDF]
de Carvalho JF, Rodrigues CEM.
europepmc +1 more source
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a double-blind randomized controlled trial. [PDF]
Medel-Jara PA +22 more
europepmc +1 more source

